Related Experiment Video
Updated: Apr 17, 2026

04:20
A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
Published on: July 28, 2020
5.7K
Monopolar soft-mode coagulation using hemostatic forceps for peptic ulcer bleeding
Hepato-Gastroenterology
|February 21, 2015
Summary
Monopolar soft coagulation effectively treated bleeding peptic ulcers in 95% of patients. This endoscopic method proved safe and feasible for managing upper gastrointestinal hemorrhage from peptic ulcers.
Area of Science:
- Gastroenterology
- Endoscopic Hemostasis
- Surgical Technology
Background:
- Upper gastrointestinal hemorrhage from bleeding peptic ulcers presents treatment challenges with conventional endoscopic methods.
- Monopolar electrocoagulation with a soft-coagulation system and hemostatic forceps (soft coagulation) is a newer technique.
- Soft coagulation has been utilized to prevent bleeding during endoscopic submucosal dissection.
Purpose of the Study:
- To evaluate the safety and efficacy of soft coagulation for treating bleeding peptic ulcers.
- To assess the hemostasis rates and rebleeding incidence associated with soft coagulation therapy.
Main Methods:
- A retrospective analysis of 39 patients with peptic ulcers treated with soft coagulation between January 2005 and March 2010.
- Emergency treatment utilized an ERBE soft-mode coagulation system with hemostatic forceps.
- Initial hemostasis, rebleeding, and ultimate hemostasis rates were analyzed, with second-look endoscopy performed to assess efficacy.
Main Results:
- Initial hemostasis was achieved in 37 out of 39 patients (95%).
- The study included 31 men and 8 women, with a mean age of 68.3 years.
- Two patients experienced rebleeding but were successfully retreated with soft coagulation.
Conclusions:
- Monopolar soft coagulation is a feasible and safe endoscopic treatment for bleeding peptic ulcers.
- The technique demonstrates high initial hemostasis rates.
- Soft coagulation offers a reliable option for managing peptic ulcer bleeding.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Peptic Ulcer Disease IV: Management
694
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
694
Peptic Ulcer Disease V: Surgical Management and Nursing Care
1.2K
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
1.2K
Introduction to Hemostasis
18.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
18.9K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.7K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.7K

